Real-world Treatment Patterns and Clinical Outcomes for Metastatic Renal Cell Carcinoma in the Current Treatment Era-Reference-Cited by-同舟云学术

Real-world Treatment Patterns and Clinical Outcomes for Metastatic Renal Cell Carcinoma in the Current Treatment Era

Published:2023-03 Issue: Volume:49 Page:110-118
ISSN:2666-1683
Container-title:European Urology Open Science
language:en
Short-container-title:European Urology Open Science

Author:

Shah Neil J.,Sura Sneha D.,Shinde Reshma,Shi Junxin,Singhal Puneet K.,Robert Nicholas J.,Vogelzang Nicholas J.,Perini Rodolfo F.,Motzer Robert J.

Publisher

Elsevier BV

Subject

Urology

Reference30 articles.

1. American Cancer Society. Key statistics about kidney cancer. https://www.cancer.org/cancer/kidney-cancer/about/key-statistics.html.

2. Surveillance, Epidemiology and End Results Program. Cancer stat facts: kidney and renal pelvis cancer. https://seer.cancer.gov/statfacts/html/kidrp.html.

3. Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial;Sternberg;J Clin Oncol,2010

4. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

5. Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial;Rini;Lancet,2011

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab;Immunotherapy;2024-08-19

2. Changes in outcome of patients with advanced non-clear cell renal cell carcinoma from the tyrosine kinase inhibitor era to the immuno-oncology era;International Journal of Clinical Oncology;2024-08-14

3. Long-Term Temporal Trends of Real-World Healthcare Costs Associated with Nivolumab Plus Ipilimumab and Pembrolizumab Plus Axitinib as First-Line Treatment for Advanced or Metastatic Renal Cell Carcinoma;Oncology and Therapy;2024-08-10

4. Upfront versus deferred cytoreductive nephrectomy following targeted or immunotherapy: a population-based propensity score-matched analysis of perioperative complications;World Journal of Urology;2024-07-27

5. Health Care Resource Use for Modern First-Line Treatments in Metastatic Renal Cell Carcinoma;JAMA Network Open;2024-07-25